|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.5 CHF | 0.00% |
|
+4.28% | -3.16% |
| Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Santhera Pharmaceuticals
will publish its
2021 Interim Report
on October 15, 2021
Attachments
Disclaimer
Santhera Pharmaceuticals Holding AG published this content on 13 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 October 2021 10:01:00 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.16% | 95.86M | |
| +5.31% | 69.91B | |
| +10.97% | 9.03B | |
| -16.83% | 4.75B | |
| +43.48% | 4.31B | |
| +3.20% | 3.88B | |
| +18.82% | 2.37B | |
| -21.36% | 2.26B | |
| -29.67% | 2.2B | |
| +8.38% | 1.98B |
SANTHERA PHARMACEUTICALS HOLDING AG 
